215 related articles for article (PubMed ID: 20064536)
1. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.
Heurteaux C; Gandin C; Borsotto M; Widmann C; Brau F; Lhuillier M; Onteniente B; Lazdunski M
Neuropharmacology; 2010 Jun; 58(7):987-1001. PubMed ID: 20064536
[TBL] [Abstract][Full Text] [Related]
2. MLC901, a traditional Chinese medicine protects the brain against global ischemia.
Quintard H; Borsotto M; Veyssiere J; Gandin C; Labbal F; Widmann C; Lazdunski M; Heurteaux C
Neuropharmacology; 2011 Sep; 61(4):622-31. PubMed ID: 21605573
[TBL] [Abstract][Full Text] [Related]
3. Activation of ATP-sensitive potassium channels as an element of the neuroprotective effects of the Traditional Chinese Medicine MLC901 against oxygen glucose deprivation.
Moha Ou Maati H; Borsotto M; Chatelain F; Widmann C; Lazdunski M; Heurteaux C
Neuropharmacology; 2012 Sep; 63(4):692-700. PubMed ID: 22659084
[TBL] [Abstract][Full Text] [Related]
4. Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: A Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study.
Young SH; Zhao Y; Koh A; Singh R; Chan BP; Chang HM; Venketasubramanian N; Chen C;
Cerebrovasc Dis; 2010; 30(1):1-6. PubMed ID: 20395679
[TBL] [Abstract][Full Text] [Related]
5. MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats.
Quintard H; Lorivel T; Gandin C; Lazdunski M; Heurteaux C
Neuroscience; 2014 Sep; 277():72-86. PubMed ID: 24993477
[TBL] [Abstract][Full Text] [Related]
6. NeuroAiD: properties for neuroprotection and neurorepair.
Heurteaux C; Widmann C; Moha ou Maati H; Quintard H; Gandin C; Borsotto M; Veyssiere J; Onteniente B; Lazdunski M
Cerebrovasc Dis; 2013; 35 Suppl 1():1-7. PubMed ID: 23548913
[TBL] [Abstract][Full Text] [Related]
7. A pharmacogenomic profile of human neural progenitors undergoing differentiation in the presence of the traditional Chinese medicine NeuroAiD.
Chan HY; Stanton LW
Pharmacogenomics J; 2016 Oct; 16(5):461-71. PubMed ID: 27044682
[TBL] [Abstract][Full Text] [Related]
8. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
[TBL] [Abstract][Full Text] [Related]
10. A novel potent radical scavenger, 8-(4-fluorophenyl)-2-((2E)-3-phenyl-2-propenoyl)-1,2,3,4-tetrahydropyrazolo[5,1-c] [1,2,4]triazine (FR210575), prevents neuronal cell death in cultured primary neurons and attenuates brain injury after focal ischemia in rats.
Iwashita A; Maemoto T; Nakada H; Shima I; Matsuoka N; Hisajima H
J Pharmacol Exp Ther; 2003 Dec; 307(3):961-8. PubMed ID: 14534357
[TBL] [Abstract][Full Text] [Related]
11. Protection of hippocampal neurogenesis by TAT-Bcl-x(L) after cerebral ischemia in mice.
Doeppner TR; Dietz GP; Weise J; Bähr M
Exp Neurol; 2010 Jun; 223(2):548-56. PubMed ID: 20156439
[TBL] [Abstract][Full Text] [Related]
12. Treatment with progesterone after focal cerebral ischemia suppresses proliferation of progenitor cells but enhances survival of newborn neurons in adult male mice.
Zhang Z; Yang R; Cai W; Bai Y; Sokabe M; Chen L
Neuropharmacology; 2010 May; 58(6):930-9. PubMed ID: 20079361
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
15. Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains.
Cai G; Liu B; Liu W; Tan X; Rong J; Chen X; Tong L; Shen J
J Ethnopharmacol; 2007 Sep; 113(2):292-9. PubMed ID: 17692486
[TBL] [Abstract][Full Text] [Related]
16. MLC901 Favors Angiogenesis and Associated Recovery after Ischemic Stroke in Mice.
Gandin C; Widmann C; Lazdunski M; Heurteaux C
Cerebrovasc Dis; 2016; 42(1-2):139-54. PubMed ID: 27099921
[TBL] [Abstract][Full Text] [Related]
17. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
18. Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia.
Culmsee C; Junker V; Thal S; Kremers W; Maier S; Schneider HJ; Plesnila N; Krieglstein J
Eur J Pharmacol; 2007 Dec; 575(1-3):57-65. PubMed ID: 17869242
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of the traditional Chinese medicine MLC901 in cognitive tasks.
Lorivel T; Gandin C; Veyssière J; Lazdunski M; Heurteaux C
J Neurosci Res; 2015 Nov; 93(11):1648-63. PubMed ID: 25821139
[TBL] [Abstract][Full Text] [Related]
20. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
